BRIEF published on 10/24/2025 at 07:05, 1 year ago BB Biotech AG publie un rapport intermédiaire soulignant une augmentation significative des bénéfices BB Biotech AG Société D'investissement Augmentation Du Bénéfice Net Rapport Intermédiaire Développeurs De Médicaments
BRIEF published on 10/24/2025 at 07:05, 1 year ago Surperformance de BB Biotech au troisième trimestre 2025 dans un contexte de reprise sectorielle BB Biotech Performances Du Troisième Trimestre 2025 Indice Nasdaq Biotechnology Thérapies À Base D'ARN Reprise Du Secteur
BRIEF published on 10/24/2025 at 07:05, 1 year ago BB Biotech's Q3 2025 Outperformance Amid Sector Recovery Sector Recovery BB Biotech Q3 2025 Performance Nasdaq Biotechnology Index RNA-based Therapeutics
PRESS RELEASE published on 10/24/2025 at 07:00, 1 year ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes interim report for the first nine months of 2025, reporting CHF 106 mn net profit. More details at report.bbbiotech.ch/Q325 Financial Results Investment Company Net Profit BB Biotech AG Interim Report
PRESS RELEASE published on 10/24/2025 at 07:00, 1 year ago BB Biotech Q3 2025: Portfolio outperformance amid early signs of sector recovery BB Biotech AG reports strong Q3 2025 performance with portfolio outperforming Nasdaq Biotech Index, driven by solid net profit, key company milestones, and strategic investments BB Biotech AG Interim Report Sector Recovery Q3 2025 Portfolio Outperformance
BRIEF published on 09/22/2025 at 07:05, 1 year 1 month ago BB Biotech Joins SPI ESG Index Biotechnology Swiss Exchange BB Biotech Sustainable Investing SPI ESG Index
BRIEF published on 09/22/2025 at 07:05, 1 year 1 month ago BB Biotech rejoint l'indice SPI ESG Biotechnologie Bourse Suisse Investissement Durable BB Biotech Indice SPI ESG
PRESS RELEASE published on 09/22/2025 at 07:00, 1 year 1 month ago BB Biotech to be included in the SPI ESG Index BB Biotech AG to be included in the SPI ESG Index by SIX Swiss Exchange, highlighting commitment to sustainability and responsible investing Sustainability SIX Swiss Exchange BB Biotech AG SPI ESG Index Responsible Investing
BRIEF published on 07/25/2025 at 07:05, 1 year 3 months ago BB Biotech AG annonce une perte intermédiaire Perte Nette Portefeuille D'investissement BB Biotech Rapport Intermédiaire Résultats Financiers 2025
BRIEF published on 07/25/2025 at 07:05, 1 year 3 months ago BB Biotech AG Reports Interim Loss Net Loss Investment Portfolio Interim Report BB Biotech 2025 Financial Results
Published on 10/29/2026 at 22:01, 1 hour 45 minutes ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended September 30, 2026
Published on 10/29/2026 at 21:30, 2 hours 16 minutes ago Shelfie Announces Amendments to Previously Announced Acquisition of Aspect
Published on 10/29/2026 at 18:30, 5 hours 16 minutes ago Kidoz Inc. Appoints Derek Sentner as Chief Revenue Officer
Published on 10/29/2026 at 16:05, 7 hours 41 minutes ago SouthGobi Announces Date of Special Meeting of Shareholders and The Record Date
Published on 10/29/2026 at 22:25, 1 hour 20 minutes ago SFC Energy continues strong, profitable growth in the first nine months of 2026 – preliminary figures – earnings guidance raised again
Published on 10/29/2026 at 22:21, 1 hour 25 minutes ago EQS-Adhoc: SFC Energy AG raises full-year 2026 earnings guidance again
Published on 10/29/2026 at 21:29, 2 hours 17 minutes ago 2CRSi SA: Publication of the consolidated annual results and the 2025-2026 Annual Financial Report postponed to 30 October 2026
Published on 10/29/2026 at 21:29, 2 hours 17 minutes ago 2CRSi SA: Report de la publication des résultats annuels consolidés et du Rapport Financier Annuel 2025-2026 au 30 octobre 2026
Published on 10/29/2026 at 21:20, 2 hours 26 minutes ago 2CRSi SA: 2CRSi publie les conclusions de l'expert indépendant mandaté à la suite du rapport Grizzly Research et apporte des précisions sur plusieurs communications antérieures
Published on 10/29/2026 at 18:02, 5 hours 44 minutes ago TF1 9M 2026 results - Consolidated financial statements and appendix
Published on 10/29/2026 at 18:02, 5 hours 44 minutes ago Résultats TF1 9M 2026 - Comptes consolidés et annexes aux comptes
Published on 10/29/2026 at 18:00, 5 hours 46 minutes ago GUILLEMOT CORPORATION: THIRD-QUARTER 2026 TURNOVER / Successful new product launches and acceleration of international commercial partnerships
Published on 10/29/2026 at 18:00, 5 hours 46 minutes ago GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2026 / Succès des nouveaux lancements et accélération des partenariats commerciaux internationaux
